NORTH RYDE, Australia, 14 March 2007--Australian biotechnology company, Peptech Limited (ASX: PTD; AIM: PTDx) today announced the appointment of Citigroup Corporate and Investment Banking to advise the company on a broad range of strategic investment opportunities designed to unlock the inherent value in its business.
